Robyn H. Guymer

Level 7, 32 Gisborne St
East Melbourne, VIC 3002, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 361 publications

Correction: Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysis.

Correction: Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysis.

Journal: Eye (London, England)

Published: August 10, 2026

Correction: Patient induced pluripotent stem cells identify specificities of a reticular pseudodrusen phenotype in age-related macular degeneration.

Correction: Patient induced pluripotent stem cells identify specificities of a reticular pseudodrusen phenotype in age-related macular degeneration.

Journal: Genome medicine

Published: July 22, 2026

How Did We Get Here? Reframing Dry Eye Disease and Charting a Path Forward.

How Did We Get Here? Reframing Dry Eye Disease and Charting a Path Forward.

Journal: Ophthalmology

Published: May 24, 2026

Non-advanced age-related macular degeneration: Current concepts and future perspectives.

Non-advanced age-related macular degeneration: Current concepts and future perspectives.

Journal: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

Published: April 09, 2026

Ground Truth Reliability and Clinical Generalisability in Deep Learning for Reticular Pseudodrusen-Response.

Ground Truth Reliability and Clinical Generalisability in Deep Learning for Reticular Pseudodrusen-Response.

Journal: Clinical & experimental ophthalmology

Published: March 02, 2026

Early Versus Delayed Pegcetacoplan Treatment for Geographic Atrophy Secondary to Age-Related Macular Degeneration in OAKS, DERBY, and GALE.

Early Versus Delayed Pegcetacoplan Treatment for Geographic Atrophy Secondary to Age-Related Macular Degeneration in OAKS, DERBY, and GALE.

Journal: American journal of ophthalmology

Published: February 24, 2026

Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysis.

Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysis.

Journal: Eye (London, England)

Published: February 14, 2026

Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysis.

Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysis.

Journal: Eye (London, England)

Published: February 14, 2026

Vision-Related Quality of Life in Geographic Atrophy: Association with Topographic Lesion Distribution.

Vision-Related Quality of Life in Geographic Atrophy: Association with Topographic Lesion Distribution.

Journal: Ophthalmology

Published: February 09, 2026

Are Ophthalmologists Ready to Manage Geographic Atrophy? Results From A National Survey.

Are Ophthalmologists Ready to Manage Geographic Atrophy? Results From A National Survey.

Journal: Clinical & experimental ophthalmology

Published: December 12, 2025

Patient induced pluripotent stem cells identify specificities of a reticular pseudodrusen phenotype in age-related macular degeneration.

Patient induced pluripotent stem cells identify specificities of a reticular pseudodrusen phenotype in age-related macular degeneration.

Journal: Genome medicine

Published: December 05, 2025

Low Rates of Fibrosis in Eyes Treated with the Port Delivery Platform with Ranibizumab or with Monthly Ranibizumab in the Archway Trial.

Low Rates of Fibrosis in Eyes Treated with the Port Delivery Platform with Ranibizumab or with Monthly Ranibizumab in the Archway Trial.

Journal: Ophthalmology science

Published: December 03, 2025

Showing 1-12 of 361

Last Updated: 09/26/2026